Serum procalcitonin concentration in children with liver disease

Area of Science:

• Pediatric Hepatology
• Clinical Biochemistry
• Infectious Diseases

Background:

• Liver disease in children presents with diverse etiologies.
• Accurate etiological diagnosis is crucial for appropriate management.
• Biomarkers can aid in differentiating causes of pediatric liver injury.

Purpose of the Study:

• To investigate the utility of serum procalcitonin as a biomarker.
• To correlate procalcitonin levels with specific mechanisms of pediatric liver injury.
• To assess procalcitonin's diagnostic value in differentiating bacterial infections from other causes.

Main Methods:

• Serum procalcitonin was measured in 58 children presenting with hepatic disease.
• Children were categorized into four groups based on the presumed cause of liver injury: invasive bacterial infection, acute viral infection, toxic liver injury, and autoimmune disease.
• Procalcitonin concentrations were analyzed across these etiological categories.

Main Results:

• All children with invasive bacterial infection showed elevated serum procalcitonin levels.
• Serum procalcitonin concentrations were low in children with viral infections and toxic liver injury.
• Approximately 50% of children with autoimmune liver disease exhibited moderately elevated procalcitonin.

Conclusions:

• Serum procalcitonin is a valuable biomarker for distinguishing invasive bacterial infections in children with liver disease.
• Low procalcitonin levels are suggestive of viral or toxic etiologies.
• Procalcitonin may be moderately elevated in autoimmune liver disease, requiring further investigation.